Do you know how celiac disease works?
Celiac disease research continues to prove the need for a non-dietary therapy, and scientists are moving closer to developing a pharmaceutical treatment. Now, it is more important than ever for patients to learn about the field of immunology - a critical piece to the celiac disease puzzle that is often left out of patient education - as well as understand the basics about the drug development and approval process.
The National Foundation for Celiac Awareness (NFCA) welcomed two immunology and pharmacology experts for a 1-hour discussion on this topic. The webinar recording and slides are now available for you to download on demand.
Topic: Celiac Disease: Immunology 101 and the Drug Development Process
- Ken Kilgore, MS, PhD, Director of ImmunoPharmacology in the Immunology Therapeutic Area at Janssen Pharmaceutical Companies of Johnson and Johnson, and Executive of NFCA Scientific/Medical Advisory Council
- Francisco Leon, MD, PhD, Vice President of Immunology Translational Medicine at Janssen Pharmaceutical Companies of Johnson and Johnson
Download & Watch the Webinar
Download the Webinar Slides
Potential Pharmaceutical Treatments for Celiac Disease
Interview with Joseph Murray, MD, celiac disease expert from the Mayo Clinic and member of NFCA's Scientific/Medical Advisory Council